Is an RSV vaccine useful for people over 60?

A vaccine against RSV (respiratory syncytial virus) may be helpful for people over 60. RSV is a common virus that usually causes mild cold-like symptoms, but in older people and people with weakened immune systems it can lead to serious complications such as pneumonia or bronchitis.

People over 60 are at greater risk of serious outcomes from RSV infection, including pneumonia, hospitalization, and in some cases, death. As we age, our immune systems become less effective, meaning infections can be more serious.

In 2023, new RSV vaccines were approved in Europe and the U.S. specifically for adults 60 years and older. These vaccines are designed to reduce the risk of serious illness and complications. Clinical studies show that the new RSV vaccines are effective in preventing serious RSV infections in older adults, particularly those at higher risk due to underlying health conditions such as heart disease, diabetes, or chronic lung disease.

Vaccination can reduce hospitalizations due to serious RSV disease, an important consideration for older adults and healthcare systems.

For people over 60, especially those with underlying health conditions, the RSV vaccine may be useful in preventing serious illness. The availability of specific vaccines for this age group provides an additional layer of protection during RSV season.

Source: https://www.ema.europa.eu/en/news/first-vaccine-protect-older-adults-respiratory-syncytial-virus-rsv-infection

Author: Prof. Dr. Dirk Devroey - Latest update: 2024-08-26 - Copyright: Clinifacts 2024